Showing results (611-620 of 631) with videos related to
Sort By:
Pageof 64
Annals of Internal Medicine|August 15, 1991
Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II TrialE G Bovill, M L Terrin, D C Stump, et al.Journal of the American College of Cardiology|June 1, 1987
A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissue-type plasminogen activator (activase) in acute myocardial infarctionE J Topol, D C Morris, R W Smalling, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 12, 2000
HDL-associated PAF-AH reduces endothelial adhesiveness in apoE-/- miceG Theilmeier, B De Geest, P P Van Veldhoven, et al.Circulation|December 1, 1984
Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trialD Collen, E J Topol, A J Tiefenbrunn, et al.Circulation|May 1, 1988
Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarctionE J Topol, R M Califf, B S George, et al.Circulation|May 23, 2001
Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient miceR Quarck, B De Geest, D Stengel, et al.Thrombosis and Haemostasis|March 4, 1991
Correlation between baseline plasminogen activator inhibitor levels and clinical outcome during therapy with tissue plasminogen activator for acute myocardial infarctionD C Sane, D C Stump, E J Topol, et al.Journal of Thrombosis and Haemostasis : JTH|September 28, 2006
Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapyT Vandendriessche, L Thorrez, A Acosta-Sanchez, et al.The Journal of Clinical Investigation|April 1, 1988
Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogsT Yasuda, H K Gold, J T Fallon, et al.Nature Medicine|December 29, 1999
PR39, a peptide regulator of angiogenesisJ Li, M Post, R Volk, et al.Pageof 64